Clinical trial
Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly…
NCT00215748 · Geriatric Oncology Consortium, Other · Terminated
Key facts
| NCT number | NCT00215748 |
|---|---|
| Title | Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel |
| Official title | Feasibility of A Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Treated With Weekly Docetaxel |
| Lead sponsor | Geriatric Oncology Consortium, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Lung Cancer |
| Intervention type | Drug |
| Interventions | Dexamethasone |
| Enrollment | 40 |
| Start date | Aug 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 16, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: